We show that loss of ANCO1 results in globally activated breast cancer enhancers, suggesting that ANCO1 may serve as a master suppressor for oncogenic transcriptional programs in breast cancer and that its loss potentially contributes to disease progression by controlling a variety of signaling mechanisms. The gene discussed is ANKRD11; the disease is breast carcinoma.